Consultation-Liaison psychiatry in a high-complexity university hospital in Turin, Italy: an observational study with a focus on delirium and predictive factors of clinical outcome Authors: Paola Bozzatello, Roberta Novelli, Rebecca Schisano, Cristiana Montemagni, Paola Rocca, Silvio Bellino Published: 2026 ABSTRACT AbstractBackground and aimThis observational study aims to provide an overview of consultation-liaison psychiatry (CLP) activity within the high-intensity, complex hospital setting of the ‘Azienda Ospedaliera Universitaria Città della Salute e della Scienza’ in Turin. The study is mainly focused on delirium-related features and predictive factors of clinical outcome.MethodA retrospective analysis was conducted on 500 psychiatric consultations provided by the University Facility of Psychiatry. Additional analysis was performed in a subgroup of patients with a diagnosis of delirium (143 subjects). The Delirium Rating Scale-Revised-98 (DRS-R-98) was administered at the time of consultation (T0) and 1 week later (T1). Descriptive statistics were performed on the whole sample. In the subgroup of patients with delirium, linear regression for continuous variables and one-way analysis of variance for categorical variables were conducted. Stepwise multiple regression was performed with ΔDRS-R-98 (difference of DRS-R-98 score between T0 and T1) as the dependent variable.ResultsThe majority of requests for consultation came from the internal medicine department or from orthopaedic and trauma units and concerned male patients with a positive history of psychiatric disorders. Although psychiatric re-evaluations were frequently required, transfers to the psychiatric ward were rare (9.8%), and there were no compulsory psychiatric admissions in our sample. In addition to delirium, the most frequent reason for requesting CLP evaluation was depressive disorder. Among the 143 cases of delirium, the mean age and prevalence of males were higher than in the whole sample. Mortality was also higher (28%) than in the whole sample (17.6%). In the stepwise multiple regression analysis, variables significantly and independently associated with ΔDRS-R-98 included: age (t=−4.074; p<0.001), treatment with benzodiazepines (BDZ) (t=−5.737; p<0.001) and treatment with atypical antipsychotics (t=3.104; p=0.002).ConclusionsCLP interventions in our high-complexity general university hospital were mainly requested for patients with mood disorders and delirium. CLP service provides an important opportunity to identify unknown psychiatric disorders or symptoms below the diagnostic threshold. Predictors of improvement of delirium-related symptoms are young age and the use of atypical antipsychotics, while BDZ treatment can be considered a negative predictor of outcome in patients with delirium. Further research on this topic is recommended to better understand the relevance of CLP, particularly the effects of this type of intervention in the management of delirium. STRENGTHS AND LIMITATIONS OF THIS STUDY Collection of real-world data in a large sample of inpatients who underwent a consultation-liaison psychiatric evaluation. Collection of real-world data in a large sample of inpatients who underwent a consultation-liaison psychiatric evaluation. Assessment with a specific scale (Delirium Rating Scale-Revised-98, DRS-R-98) to identify potential factors that predict poor outcomes and identify high-risk patients for developing delirium. Assessment with a specific scale (Delirium Rating Scale-Revised-98, DRS-R-98) to identify potential factors that predict poor outcomes and identify high-risk patients for developing delirium. Sociodemographic and clinical data were retrospectively collected. Sociodemographic and clinical data were retrospectively collected. Clinical course was assessed using a specific scale (DRS-R-98) only in patients diagnosed with delirium. Clinical course was assessed using a specific scale (DRS-R-98) only in patients diagnosed with delirium. Potential sources of bias were not considered. Potential sources of bias were not considered. Introduction In recent decades, psychiatric research has increasingly identified Consultation-Liaison Psychiatry (CLP) as ‘the custodian of a holistic approach to the patient’,1 underscoring its pivotal role in the management of hospitalised patients. The aims and operational modalities of CLP have evolved significantly, progressing from basic psychiatric assessment to the integration of care within a biopsychosocial framework.2 3 Hospital staff face complex clinical scenarios involving both physical and psychiatric multimorbidity, alongside a growing awareness of the interdependence between psychological and physical dimensions of illness.4 CLP services are essential for managing patients with multimorbidity and medically unexplained physical symptoms, fostering effective physician–patient relationships, improving treatment adherence and preventing psychiatric complications during somatic illness, such as depressive symptoms or delirium.5 There is a broad consensus regarding the impact of psychosocial factors on the pathogenesis and prognosis of chronic diseases such as ischaemic heart disease, diabetes and cancer.6 These complex clinical conditions contribute to increased patient suffering and a greater burden on healthcare resources.2 Psychiatric disorders, even when subclinical, negatively influence disease progression, prolong hospital stays and are associated with increased mortality rates.7 8 Although early identification and treatment of psychiatric comorbidities have shown to significantly reduce healthcare costs, for example producing shorter lengths of stay,9 10 Italy still lacks a widely implemented and standardised model for CLP interventions. This awareness has not yet been translated into substantial changes in clinical research or routine practice, particularly regarding interventions that target both patients and healthcare professionals across various hospital departments. Such challenges highlight the need for multidisciplinary teams, with the psychiatrists playing a key role in facilitating integration through CLP systems. Furthermore, CLP faces specific difficulties, including patients’ limited insight into their psychiatric conditions and the resulting deficiency of spontaneous help-seeking behaviour.4 11 From a research perspective, studies investigating this issue are scarce and methodologically heterogeneous. Furthermore, available studies lack follow-up and long-term outcome data.12 Psychiatric consultations are considered clinically valuable and contribute meaningfully to patient care through well-organised services, team expertise and continuity of care.13 However, the consulting psychiatrist, tasked with coordination, training and liaison functions,11 requires standardised procedures, evidence-based guidelines and quality indicators.14 A preceding experience in an Italian Hospital4 allowed to describe how CLP is organised and delivered in our country: (1) requests were sent by a restricted access online system with a clear clinical question, (2) consultation was delivered within 24 hours, (3) a qualitative method was preferred to a quantitative one, (4) clear indications were provided in a written clinical report to allow a multidisciplinary approach and better collaboration with colleagues and (5) a link with community health and social services is useful to guarantee appropriate treatment and follow-up after discharge. In addition to providing an overall description of the CLP service in a highly complex university hospital, a portion of our study focuses on patients referred to CLP services for ‘delirium,’ as approximately one-third of consultations in our sample are required for the management of delirium-related symptoms. Delirium is an acute mental dysfunction characterised by a sudden disturbance in cognitive performance, primarily attention and awareness, often accompanied by alterations in arousal and a fluctuating course. It may be triggered by several factors, including acute illness, substance use or withdrawal, trauma and medical or surgical procedures.15 16 Three clinical subtypes are recognised: hyperactive, hypoactive and mixed.17 The hyperactive subtype is characterised by restlessness, agitation and/or aggression, whereas the hypoactive subtype is characterised by lethargy and reduced psychomotor activity.18 Delirium is associated with increased mortality, cognitive and functional decline and prolonged hospitalisation.19 20 Although it can occur in all hospital wards,21 22 delirium has a particularly high prevalence in surgical units, with postoperative delirium affecting 20%–50% of patients over 60 undergoing surgery.23 In intensive care units, the overall prevalence is estimated to be over 30%, reaching up to 80% in mechanically ventilated patients.24 25 To mitigate the incidence and burden of delirium across patient populations, some clinical guidelines have been developed for its prevention and management.26 27 While systematic reviews and meta-analyses have evaluated therapeutic strategies for delirium, most have done so in isolation. The heterogeneity of the evidence, the indirectness of analyses and limitations due to restricted clinical settings, driven by issues of heterogeneity and transitivity, limit the real-world applicability of current findings.16 28 29 This observational study aims: to provide a comprehensive overview of demographic and clinical characteristics of a large sample of inpatients who receive a CLP intervention in the high-intensity and high-complexity clinical setting of the ‘Città della Salute e della Scienza’ University Hospital in Turin, Italy, during a period of 2 years; to provide a comprehensive overview of demographic and clinical characteristics of a large sample of inpatients who receive a CLP intervention in the high-intensity and high-complexity clinical setting of the ‘Città della Salute e della Scienza’ University Hospital in Turin, Italy, during a period of 2 years; to evaluate in patients with a diagnosis of delirium, demographic and clinical variables associated with delirium-related symptoms and identify predictive factors of improvement/impairment of delirium-related symptoms. to evaluate in patients with a diagnosis of delirium, demographic and clinical variables associated with delirium-related symptoms and identify predictive factors of improvement/impairment of delirium-related symptoms. Material and methods Subjects This study involved 500 inpatients admitted to the university-affiliated departments of the Hospital ‘Città della Salute e della Scienza’ in Turin, Italy, who received psychiatric consultation from the University Facility of Psychiatry of the Department of Neuroscience and Mental Health. All CLP interventions were requested by the hospital wards where the patients were admitted. Participants were enrolled between January 2023 and December 2024. Data were collected only for patients who had signed the informed consent (also for research purposes) at admission to the hospital, regardless of the type of department. Data relating to 15% of patients who received CLPs were excluded because they did not sign the consent to the processing of their data for research purposes. The study strictly adhered to the EU Council regulations regarding the processing of biomedical data30 . Inclusion and exclusion criteria All routine consultation requests from University-affiliated departments of the Hospital ‘Città della Salute e della Scienza’ in Turin were included. Emergency consultations were excluded from the sample. Participants All inpatients for whom one or more psychiatric consultations were requested during the period of hospitalisation in the University-affiliated departments of the Hospital ‘Città della Salute e della Scienza’ in Turin. The assessments were carried out on request by the wards where the patients were hospitalised. Assessment Sociodemographic and clinical characteristics were collected during psychiatric evaluation. Medical histories were gathered through the hospital electronic medical record and from other available clinical documents. Data were entered into a password-protected database. We evaluated the following variables: age, gender, hospital ward, psychiatric history, reason for consultation, history of self-harm or suicide attempts, duration of hospitalisation, discharge destination, death during hospitalisation, number of days between discharge and death (if applicable), psychotropic treatments and referral to community mental health services. Patients were assessed for delirium-related symptoms at first psychiatric evaluation (baseline-T0) and after 1 week (T1) using the Delirium Rating Scale-Revised-98 (DRS-R-98), an observer-rated scale. The DRS-R-98 is a revised version of the DRS.31 It is used for both initial assessment and repeated measurement of delirium symptom severity. The total score for the 13 severity items reflects overall delirium severity. Information from all available sources (nurses, caregivers, clinical records) is used alongside direct patient examination. For repeated assessments, time intervals must be reasonable to detect changes. The scale, usually, is re-administered 1 week after the initial assessment. The 13 severity items include: Sleep-wake cycle disturbance, Perceptual disturbances and hallucinations, Delusions, Lability of affect, Language, Thought process abnormalities, Motor agitation, Motor retardation, Orientation, Attention, Short-term memory, Long-term memory, Visuospatial ability. Each item is assigned a score from 0 to 3. Scores range from 0 to 39, with higher scores indicating greater severity. In addition, three diagnostic items (temporal onset of symptoms, symptom fluctuation and physical disorder) assist in distinguishing delirium from other clinical conditions. The score of these three items is not included in the total severity score. Statistical analyses Statistical analyses were performed using the SPSS, V.29 for Windows (IBM). A descriptive statistical analysis was performed on the whole sample of hospitalised patients receiving a consultation. Subsequently, only psychiatric consultations requested for a diagnosis of delirium were selected. In this subsample, linear regression was performed to evaluate the relationship between ΔDRS-R-98 and continuous variables: age, length of hospitalisation and the DRS-R-98 score at baseline. ΔDRS-R-98 is the difference of the DRS-R-98 score between T0 and T1, indicating the improvement/impairment of delirium-related symptoms. In the subgroup of patients with delirium, ΔDRS-R-98 is the primary outcome of the study. In addition, a one-way analysis of variance (ANOVA) was performed to evaluate the difference of mean ΔDRS-R-98 according to categorical variables (gender, positive psychiatric history, department of origin—surgical or medical, current or past suicide attempts, use of antidepressants, mood stabilisers, benzodiazepines (BDZ), typical antipsychotics, atypical antipsychotics, need for follow-up consultation, discharge to home, transfer to neuropsychiatric rehabilitation facilities, death rate during hospitalisation). All sociodemographic and clinical variables that were found statistically significant, except rate of death, were included in a stepwise multiple regression analysis. The regression was performed using ΔDRS-R-98 as the dependent variable. The level of statistical significance was set at p≤0.05. No missing data were found for the variables under investigation. Patient involvement In this observational study conducted in hospitalised patients with general clinical conditions significantly compromised, as far as possible, patients were informed about the rationale for the study and the outcome measures that were assessed. Results Total sample A total of 500 patients were included in the sample. The mean age was 64.1 years (SD=±17.9, range: 18–96 years), with 59.8% being male and 40.2% female. Regarding psychiatric history, 44% of patients had no prior psychiatric diagnosis. Among 56% of patients with a positive psychiatric history, 16% suffered from major depression, 13% from substance and/or alcohol use disorders, 10.2% from anxiety disorders, 6.2% from bipolar disorders, 4.6% from schizophrenia or other psychotic disorders, 4.2% from personality disorders, 1.2% from eating disorders, and 0.6% from obsessive-compulsive disorder. A history of at least one suicidal attempt (current or past) was reported in 10.4% of patients. CLP requests included: reassessment of a prior psychiatric diagnosis (23.8%), assessment of mood deflection (21%), delirium (18.2%), psychomotor agitation (10.2%), anxious-depressive syndrome (3.4%), anxiety (3.4%), cognitive deterioration (3.4%), substance-related acute conditions (3.4%), restlessness (2.2%), hallucinations (2%), conversion symptoms (1.8%), impairment of decision-making capacity (1.8%), craving (1.6%), delirium tremens (1.6%), eating behaviour disorder (0.6%), hyperthymia (0.6%), emotional lability (0.4%), insomnia (0.4%) and aggressiveness (0.2%) (figure 1). Distribution of hospital departments and of the clinical questions requesting psychiatric consultation referrals in the total sample. (N= 500). CLP requests came from units of medicine in 68.2% of cases and from units of surgery in 31.8% of patients. In detail, psychiatric consultations were requested by: internal medicine (35%), orthopaedic and trauma units (10.2%), neurology (9%), general surgery (8.2%), nephrology (6.4%), cardiology (5.4%), geriatrics (4.4%), neurosurgery (3.6%), cardiac surgery (3.2%), urology (2.4%), anaesthesia and intensive care (2%), pulmonology (1.8%), thoracic surgery (1.8%), vascular surgery (1.6%), gastroenterology (1.4%), dermatology (0.8%), plastic surgery (0.8%), endocrinology (0.6%), otolaryngology (0.6%), dietology and nutrition (0.4%), and haematology (0.4%) (figure 1) A second or further psychiatric evaluation was required in 32.8% of patients. From a psychopharmacological standpoint, CLP led to prescription or confirmation of treatment with antidepressants in 45.8%, BDZ in 38.2%, atypical antipsychotics in 36.6%, typical antipsychotics in 18.4% and mood stabilisers in 7.4% of patients. The mean duration of hospitalisation for patients receiving CLP consultation was 30.4 days (SD=±36.9, range: 1–361 days). On discharge from the ward that requested psychiatric consultation, 4.6% to a psychiatric inpatient unit, and 5.2% of patients were transferred to a neuropsychiatric rehabilitation facility. 63.6% of patients were discharged at home, while the remaining were transferred to non-psychiatric rehabilitation centres. No compulsory psychiatric treatment was found in our sample, probably due to the fact that all consultation visits were delivered under ordinary conditions (not under emergency situations). A total of 17.6% of patients died, with 15.9% of them passing away during hospitalisation and 84.1%, on average, 143 days postdischarge. Subgroup: patients undergoing psychiatric consultation for delirium-related symptoms A total of 143 patients (28.6% of the total sample) were evaluated by a consultation psychiatrist for delirium-related symptoms. The mean age in this subgroup was 74.2 years (SD = ±12.3, range: 36–96 years), with 65.7% of participants being males and 34.3% females. A prior psychiatric diagnosis was not recorded in 67.8% of patients. Among patients with a history of psychiatric disorders who developed delirium, 9.1% suffered from major depression, 14% from substance and/or alcohol use disorders, 4.2% from anxiety disorders, 2.1% from bipolar disorders, 1.4% from schizophrenia and other psychotic disorders, and 1.4% from personality disorders. The majority of patients did not attend psychiatric services (81.8%); 11.2% attended mental health centres, and 7% attended services for addiction/dependence. In the subgroup of hospitalised patients with delirium, psychiatric consultation was requested with the following clinical questions: delirium (63.6%), psychomotor agitation (18.2%), hallucinations (6.3%), delirium tremens (5.6%), cognitive impairment (3.5%) and restlessness (2.8%) (figure 2). Distribution of hospital departments and of the clinical questions requesting psychiatric consultation referrals in the subgroup with delirium (N= 143). Consultation requests came from units of medicine in 70.6% of cases and from units of surgery in 29.4% of patients with the following distribution: internal medicine accounted for 37.7% of cases, cardiology for 9.1%, nephrology for 7.7%, general surgery for 6.3%, cardiac surgery for 5.6%, urology for 4.9%, geriatrics for 4.9%, neurosurgery for 4.2%, orthopaedic and trauma units for 3.5%, neurology for 3.5%, pulmonology for 2.8%, vascular surgery for 2.8%, thoracic surgery for 2.1%, anaesthesia and intensive care for 1.4%, gastroenterology for 1.4%, plastic surgery for 0.7%, endocrinology for 0.7%, and haematology for 0.7%. A second or further psychiatric evaluation was required in 35% of patients in the subgroup with delirium. Regarding psychopharmacological interventions, CLP led to prescription or confirmation of treatment with atypical antipsychotics (67.8%), typical antipsychotics (41.3%), BDZ (22.4%), antidepressants (16.1%) and mood stabilisers (2.1%). The mean duration of hospitalisation was 26.8 days (SD=±25.6, range: 4–174 days). On discharge from the ward that requested the psychiatric consultation, 4.2% to a psychiatric inpatient unit, and 4.9% of patients were transferred to a psychiatric rehabilitation facility. 59.4% of cases were discharged at home, while 31.5% were transferred to non-psychiatric rehabilitation centres. The rate of death was 28%. Among dead subjects, 5.6% died during hospitalisation, and the remaining died on average 30.7 days after discharge (SD=± 105.1). The average severity score for delirium symptoms at the time of the first assessment, calculated using the DRS-R-98 scale, is 21.8 (SD±12). The average score on the DRS-R-98 scale at the second assessment is 14.7 (SD±9.6). The demographic and clinical characteristics of the total sample (patients without delirium and patients with delirium) and the delirium subgroup are summarised in table 1. Table 1Demographic and clinical variables in the total group of CLP and in the subgroup with deliriumVariablesTotal sample n=500Delirium n=143Age, mean±SD64.1 years±17.974.2 years±12.3Male gender, %59.865.7Positive psychiatricanamnesis, %5632.2Known to psychiatric services, %34.618.2Suicidal attempts, %10.44.2Second CLP, %32.835Antidepressants, %45.816.1BDZ, %38.222.4Mood stabilisers, %7.42.1Typical antipsychotics, %18.441.3Atypical antipsychotics, %36.667.8Hospital stay, mean±SD30.4 days±36.926.8 days±25.6Discharged at home, %63.659.4Transfer to non-neuropsychiatric rehabilitation centres, %26.631.5Transfer to psychiatry department, %4.64.2Transfer to a neuropsychiatric care facility, %5.24.9Compulsory admissions, %00Rate of death, %17.628DRS-R-98 score at baseline±SD/21.8±12Follow-up DRS-R-98 score±SD/14.7±9.6BDZ, benzodiazepine; CLP, Consultation-Laison Psychiatry; DRS-R-98, Delirium Rating Scale-Revised-98. Demographic and clinical variables in the total group of CLP and in the subgroup with delirium BDZ, benzodiazepine; CLP, Consultation-Laison Psychiatry; DRS-R-98, Delirium Rating Scale-Revised-98. According to results of linear regressions, the continuous variables that were found significantly related to the ΔDRS-R-98 score were: age (t = −2.482; p=0.015) and the DRS-R-98 score at baseline (t=6.280; p<0.001). Results of the one-way ANOVA analysis were the following: categorical variables that were found to be significantly associated with the ΔDRS-R-98 were: rate of death (F=7.665; p=0.007), treatment with BDZ (F=3.571; p=0.004), treatment with atypical antipsychotic (F=5.300; p=0.023), positive psychiatric history (F=3.260; p=0.05) and transfer to a neuropsychiatric rehabilitation facility (F=7.542; p=0.007) (table 2). Table 2Results of one-way ANOVA using ΔDRS-R-98SampleMean valueDSFP valueRate of deathYes542.863611.909727.6650.007No897.38365.67066Therapy with BDZYes493.575010.743843.5710.0041No946.77927.43679Therapy with atypical antipsychoticsYes1046.81188.800025.3000.023No392.68758.18116Positive psychiatric historyYes403.36369.420123.2600.05No1036.59528.42274Continuation of treatment in a neuropsychiatric rehabilitation facilityYes6−4.60009.989997.5420.007No1376.14298.50210ANOVA, analysis of variance; BDZ, benzodiazepine; DRS-R-98, Delirium Rating Scale-Revised-98; F, Fisher variable. Results of one-way ANOVA using ΔDRS-R-98 ANOVA, analysis of variance; BDZ, benzodiazepine; DRS-R-98, Delirium Rating Scale-Revised-98; F, Fisher variable. In the stepwise multiple regression analysis, variables significantly and independently related to ΔDRS-R-98 (dependent variable) were: age (t = −4.074; p<0.001), the DRS-R-98 score at baseline (t=8.821; p<0.001), treatment with BDZ (t = −5.737; p<0.001), and therapy with atypical antipsychotics (t=3.104; p=0.002). The details of these data are presented in tables 3 and 4. Table 3Results of multiple regression analysis (stepwise) using ΔDRS-R-98 as dependent variableBSEtP valueAge−0.2230.055−4.074<0.001Therapy with BDZ−7.7111.344−5.737<0.001Therapy with atypical antipsychotics4.4291.3853.1040.002B, unstandardised b coefficient; BDZ, Benzodiazepine; DRS-R-98, Delirium Rating Scale-Revised-98; t, t-value. Results of multiple regression analysis (stepwise) using ΔDRS-R-98 as dependent variable B, unstandardised b coefficient; BDZ, Benzodiazepine; DRS-R-98, Delirium Rating Scale-Revised-98; t, t-value. Table 4Variables excluded from multiple regression analysis (stepwise)Beta intP valuePositive psychiatric history0.0640.9310.354Continuation of treatment in a neuropsychiatric rehabilitation facility−0102−14810.142Beta in, coefficient Beta in; t, t-value. Variables excluded from multiple regression analysis (stepwise) Beta in, coefficient Beta in; t, t-value. Discussion Findings of this observational study provided a meaningful overview of clinical and demographic characteristics of a large sample of inpatients who underwent psychiatric consultation interventions during a hospitalisation period in a high-complexity university hospital in northern Italy, with an estimated annual number of admissions of around 50 000 patients. The assessments were carried out at the request of the departments where the patients were hospitalised. These are clinical assessments, mainly aimed at introducing psychopharmacological therapies, often after an initial pharmacological attempt carried out in the unit where the patients are hospitalised. We would like to point out that no assessments were carried out on cancer patients, as our hospital offers a psycho-oncology service. Psychological assessments are also mainly carried out by a service other than ours, namely, clinical psychology. Globally, CLP intervention was mainly requested for a middle-aged population, as indicated by the mean age of the sample (mean 64.1 years), with a mild predominance of consultations for male gender (59.8%). No CLP interventions were offered to patients under the age of 18, as the CLP service is active exclusively for adult patients. The data obtained from this study suggested that psychiatric consultation in a general hospital setting is often needed as the first psychiatric evaluation for medically and psychologically vulnerable individuals, in line with previous literature stating that 27% of medical emergency admissions had diagnosable psychiatric disorders, mostly mild in severity.32 Hospital admission for medical or surgical pathology is often the first step to accessing mental health services, particularly for older adults and patients with significant medical comorbidities.33 In our sample, 44% of the patients did not have a history of psychiatric disorders, indicating that CLP interventions frequently represent the first contact with psychiatric services. We can hypothesise that some psychopathological conditions, such as mild depression and anxiety, are initially under-recognised or underestimated by the patients and tend to surface in the context of acute medical illness during hospitalisation. Among patients with a positive psychiatric history (56% of the total sample), the most frequent diagnoses were mood disorders, including unipolar depression (16%) and bipolar disorder (6.2%), followed by substance and/or alcohol use disorder (13%), anxiety disorders (10.2%), and psychotic spectrum disorders (4.6%), personality disorders (4.2%), eating disorders (1.2%) and obsessive–compulsive disorder (0.6%). A relevant finding is the presence of a history of at least one suicide attempt in 10.4% of patients, underlining the critical need for thorough suicide risk assessment in hospital settings. Hospitalisation thus represents a valuable opportunity to identify individuals at high risk of self-harm or suicide and to initiate appropriate interventions. The clinical issues requiring CLP interventions were heterogeneous, the most common being to optimise pre-existing psychoactive therapy (22.8%). This finding suggests both an inadequate control of emerging symptoms under current therapy and the necessity to adapt pharmacological strategies to the new medical condition of patients with particular attention to drug-drug interactions. Additional frequent reasons for requesting psychiatric consultation included mood deflection (21%) and delirium (18.2%), followed by psychomotor agitation (10.2%), anxiety (3.4%), anxious-depressive symptoms (3.4%), and cognitive decline (3.4%). These clinical conditions often require quick diagnostic and therapeutic redefinition, reinforcing the central role of CLP in multidisciplinary decision-making and in managing complex comorbidities. Most CLP requests came from medicine departments (68.2%), particularly internal medicine wards (35%). Among surgery wards, referrals were more frequent from orthopaedics, traumatology, and plastic surgery units (10.2%), as well as general surgery (8.2%). This distribution reflects the high complexity of cases in internal medicine, where the duration of hospitalisation is mainly higher and the interaction between physical and mental health conditions is more prevalent and harder to disentangle. Approximately one-third of patients (32.8%) required a second psychiatric assessment, suggesting the persistence or evolution of psychiatric symptoms over time. Medications more commonly prescribed or confirmed during CLP interventions were antidepressants (45.8%) and anxiolytics (38.2%), in line with the high prevalence of anxiety-depressive symptoms. The considerable use of antipsychotics (18.4% typical, 36.6% atypical) aligns with the number of referrals for psychotic symptoms, delirium and psychomotor agitation. At discharge, 63.6% of patients returned home. Among patients requiring further psychiatric care after discharge, 5.2% were admitted to neuropsychiatric rehabilitation facilities and 4.6% to psychiatric hospital wards. These findings emphasise once again that patients with subthreshold or unrecognised psychiatric symptoms may experience a worsening of their mental health during hospitalisation for medical or surgical pathology and need to receive a follow-up with diversified, coordinated post-discharge pathways that involve the use of rehabilitation facilities. The global average duration of hospitalisation was notably high (mean: 30.4 days), and nearly one-fifth of patients (17.6%) died during or shortly after the period of hospitalisation (mean: 143 days). The relatively high mortality rate among patients who needed psychiatric consultations may be an indicator that patients with psychiatric symptoms or disorders in comorbidity have a poorer prognosis.34 Diagnosis of delirium seems to mainly impact the death rate (28%) in comparison with the death rate of patients who received CLP evaluation for other reasons (11.2%). When we examined data concerning the subgroup of 143 patients who underwent CLP interventions for delirium or related symptoms, it emerged that the mean age of patients was significantly higher (74.2 years), as well as the prevalence of male gender (65.7%). These data are consistent with previous available evidence that stated that older age and medical comorbidity can be considered risk factors for delirium and that delirium-related symptoms are more prevalent in male gender.35 In our sample, requests for psychiatric consultations for delirium came from all inpatient wards, in line with existing literature.35 36 Patients with delirium-related symptoms were mainly treated with atypical (67.8%) and typical (41.3%) antipsychotics, following clinical guidelines for delirium management.26 BDZ were administered after CLP evaluation in patients with active alcohol use disorder and related withdrawal symptoms or in cases of delirium tremens (22.4%). The mortality rate in the subgroup of patients suffering from delirium was higher (28%) than the death rate in the total sample (17.6%) and the death rate in the total sample, except for cases of delirium (11.2%). These data support that delirium is a condition with a poor prognosis, associated with an increased risk of medical complications, prolonged hospital stay and short-term mortality.37 38 In our sample, inpatients with delirium admitted to internal medicine departments showed more severe symptoms (DRS-R-98 at baseline: mean±SD=22.15 ± 11.74) than inpatients with delirium admitted to surgery units (DRS-R-98 at baseline: mean±SD=19.64±12.34). This difference could reflect different approaches: surgery teams, who are probably less equipped to manage complex neuropsychiatric conditions, may request specific consultation in advance, while internal medicine teams may delay referral until symptoms become more refractory. In general, after CLP evaluations, we observed a reduction in the severity of delirium-related symptoms, measured with the difference of DRS-R-98 score between the first and second assessments (ΔDRS-R-98: mean±SD=3.66±8.96). This suggests a favourable response to psychiatric and multidisciplinary interventions. In the linear regression analysis, ΔDRS-R-98 (indicating the change of severity of delirium-related symptoms over time) was found to be associated with the age of patients and to delirium-related symptoms severity at the first evaluation (DRS-R-98 score at baseline). In particular, younger patients showed a greater potential for symptom improvement. While it is well established that delirium can affect individuals across a wide age range and with varying severity, older adults are more likely to experience slow and incomplete recovery, likely due to reduced brain trophism and pre-existing cerebral damage.37 39 40 DeCrane et al39 suggested that, in patients aged ≥80 years, predisposing factors alone were almost sufficient to cause delirium, whereas in individuals aged 18–80 years, additional precipitating factors were needed. We also observed that patients with more severe initial delirium (measured by DRS-R-98 score at baseline) showed greater improvement during hospitalisation. This phenomenon is documented in the literature for other psychiatric conditions.41 42 One-way ANOVA analysis revealed a statistically significant association between a higher rate of death and a lower improvement of delirium-related symptoms during hospitalisation. This finding underscores the critical importance of early diagnosis and preventive strategies. Traditionally, treatment approaches for delirium and psychomotor agitation have focused on addressing underlying medical causes, integrating both pharmacological (eg, antipsychotics) and non-pharmacological interventions.43 44 Current guidelines by the Society of Critical Care Medicine strongly recommend non-pharmacological interventions as first-line strategies.26 These approaches include mitigation of risk factors (eg, sleep hygiene), individualised analgesia and sedation regimens (eg, avoiding BDZ), and promotion of early mobility.43 45 Emerging research not only supports non-pharmacological methods but also highlights the efficacy of family support and light therapy. In contrast, the role of pharmacological prevention remains uncertain.45 46 Consistent with existing literature, our data showed that BDZ-based treatment was associated with worsening delirium-related symptoms,46 while symptom improvement was associated with the use of antipsychotics, particularly atypical antipsychotics. These findings align with existing literature suggesting that BDZ, due to their sedative effect, may exacerbate delirium symptoms.43 44 46 BDZ are effective in a particular type of delirium, delirium tremens, and/or in cases where delirium-related symptoms are provoked by alcohol withdrawal.47 However, in our cohort of 500 patients, delirium tremens was registered only in 5.2% of cases. Concerning antipsychotics, haloperidol, a typical antipsychotic, was widely used for both treatment and prevention of delirium-related symptoms, but its efficacy has to be balanced with the concerns about safety and adverse effects.43 With a more favourable tolerability profile, atypical antipsychotics have shown good efficacy in reducing delirium-related symptoms. In particular, quetiapine obtained a good level of evidence, whereas data available on aripiprazole, olanzapine and risperidone are still scarce to draw reliable conclusions.46 48 Another notable finding of our investigation is that patients with a psychiatric vulnerability, defined by a positive psychiatric history (including psychotic spectrum disorders, mood disorders, personality disorders, substance or alcohol use disorders, anxiety disorders, eating disorders or obsessive-compulsive disorder), showed a less favourable trajectory of delirium symptoms compared with those without a psychiatric history, regardless of the psychiatric diagnosis at the moment of the consultation. To our knowledge, only one study found a specific association between previous psychiatric diagnoses (in particular depression and dementia) and higher severity of delirium.34 Nonetheless, other studies confirmed the association between positive psychiatric history and higher incidence and longer duration of delirium symptoms.40 49 50 Moreover, patients with a positive psychiatric history and poor delirium outcome were more likely to be transferred to neuropsychiatric rehabilitation facilities, reflecting the need for an extended time of recovery. This is in line with existing literature linking delirium to a decreased likelihood of returning home, increased chances of discharge to higher-dependency settings and higher mortality rate, independent of comorbidities, age or gender.51 These findings highlight the potentially devastating consequences of delirium and reinforce the need for timely diagnosis and effective inpatient management to avoid prolonged hospitalisation and complex discharge planning. One of the objectives of the present study was to identify potential factors predicting the course of delirium. To our knowledge, there are no available studies that specifically investigated predictive factors of outcome in patients with delirium. So, our results cannot be compared with the preceding data. In our study, we found that older age may predict a poor outcome. In addition to what has already been discussed above, in the literature it is indicated that older patients with predelirium syndrome have a higher risk of developing full delirium syndrome and more prolonged symptoms, especially in intensive care units.52 53 From a therapeutic perspective, treatment with BDZ can be considered a negative predictive factor for the course of delirium. This result is in accordance with treatment guidelines for delirium,26 suggesting that the use of BDZ is a modifiable risk factor for delirium onset. On the contrary, in our sample, atypical antipsychotics can be considered a positive predictive factor for delirium regression. These findings suggest that older patients in treatment with BDZ should be monitored with attention for delirium or pre-delirium onset during hospitalisation. Atypical antipsychotics should be considered protective for patients in whom non-pharmacological interventions have failed. The study has some limitations: (1) the naturalistic and retrospective design of the study, (2) there may be additional clinical predictors that were not captured but can be clinically important, (3) a short follow-up evaluation was provided only for delirium-subgroup patients, (4) no long-term follow-up evaluation was performed in the whole sample and (5) the study design cannot allow us to draw causal inferences. Future prospective studies would be beneficial—standardising and expanding clinical variables and assessment tools, as well as incorporating post-discharge follow-up, particularly for patients diagnosed with delirium. Conclusions This study provides a comprehensive overview of the demographic and clinical characteristics of a large sample of patients who received CLP interventions in a high-complexity university hospital in Northern Italy. The findings highlighted the crucial role of CLP in identifying unrecognised psychiatric conditions, optimising pharmacological management in medically impaired individuals and facilitating appropriate discharge planning. Delirium emerged as a frequent and clinically significant syndrome within the CLP population, characterised by advanced age, higher mortality rate and increased symptom severity. Our data reinforced the notion that delirium is not only a marker of acute psychiatric dysfunction but also a predictor of poor short-term outcome, including reduced functional recovery and increased likelihood of institutionalisation or death. We observed that younger patients showed a greater potential for symptom improvement, patients with more severe delirium-related symptoms at the initial evaluation showed greater improvement during hospitalisation, a higher rate of mortality was associated with a lower improvement of delirium-related symptoms during hospitalisation, patients with a positive psychiatric history showed a less favourable trajectory of delirium symptoms. The most significant predictors of poor delirium outcome included older age and BDZ treatment. On the other hand, treatment with atypical antipsychotics was associated with a more favourable clinical outcome. These results supported the growing body of literature advocating for early identification, non-BDZ pharmacological strategies and integrated multidisciplinary care in the management of delirium. More broadly, this study emphasises the need for a hospital organisation that can strengthen the integration between internal medicine, surgery and mental health services. CLP interventions are often the first point of psychiatric contact for patients, underscoring their potential as a gateway to long-term psychiatric care and prevention strategies. Future research should build on these findings, adopting prospective designs, extended follow-up periods and standardised methods of assessment to improve our understanding of the impact of delirium on mental functioning and optimise treatment pathways for this high-risk population.